This post discusses some of the current outpatient treatment options for Covid-19. Also included is Dr. Orban’s personal experience with covid and information about Covid-19 research studies being conducted by researchers within our Department, including ACTIV-6, an NIH sponsored study looking at outpatient treatment options for Covid-19.
Read MoreDr. Jason Wilson revisits the use of fluvoxamine in the treatment of Covid-19. He discusses an exciting study recently published in Lancet Global Health that may change how doctors are treating Covid-19.
Read MoreDr. Jason Wilson discusses a recent, small randomized controlled trial published in JAMA which investigated the use of fluvoxamine, an SSRI, as a therapeutic treatment option for Covid. The results of the study and the proposed mechanism are quite interesting. Find out why fluvoxamine is not ready for prime time, but SSRIs may deserve funding for larger clinical studies.
Read More
